Skip to main content
. 2017 Jun 7;23(21):3797–3804. doi: 10.3748/wjg.v23.i21.3797

Table 1.

Clinical characteristics of spontaneous regression of hepatocellular carcinoma

Ref. Age Sex Country Etiology Background liver Size (mm) Location Impaired blood flow Pre AFP Post AFP Pre DCP Post DCP Histological Diagnosis Following therapy Recurrence Intrahepatic metastasis Extrahepatic metastasis Proposed mechanism Cause
Jianxin et al[11] 64 M China HBV CH 92 S6 N/A 9022 2516 N/A N/A N/A N N N Omentum Immunological Herbal medicine
Saito et al[12] 74 M Japan Alc CH 36 S8 N/A 31 3 17 N/A N/A Resection N N N Immunological Cessation of drinking and smoking
Pectasides et al[13] 53 M United States HCV/Alc LC 90 Left PV, HA 602410 2177 N/A N/A N/A N Remnant Y Lung Combine Portal vein thrombosis and immunological reaction
Alam et al[14] 65 M United Kingdom HCV LC N/A S5/6 N 2893 6 N/A N/A N/A N Y N LNs Combine Rapid tumor growth and immunological reaction
Kumar et al[15] 40 M United States N/A N/A 26 S2/3/5 N/A 832 2 N/A N/A Poor Radiation N Y Lung Immunological Cessation of immunosuppressive Therapy
Kumar et al[15] 74 M United States N/A N/A 56 Right N/A 97932 722 N/A N/A Poor N Remnant Y N Immunological Cessation of immunosuppressive Therapy
Yang et al[16] 59 M China HBV N/A 40 S6 N/A 2100 N/A N/A N/A N/A N Y Y N Immunological Seroconversion of HBV
Okano et al[17] 73 M Japan HBV N/A 15 S8 N/A 748 5 20 N/A N/A N N N N N/A Angiography
Takeda et al[18] 68 M Japan Alc CH 30 S4 Y 2 2 427 41 N/A Resection N N N Hypoxia Hepatic arterioportal shunts and vessel thrombosis
Kim et al[19] 57 M South Korea HBV LC 37 S6 N 4778 50 22 N/A N/A Resection N N N Immunological Unknown
Matsuoka et al[20] 67 M Japan NASH CH 43 S6 PV, HA 11 N/A 6 N/A Moderate Resection N N N Hypoxia Hepatic arterial and portal vein thromboses
Wang et al[21] 50 M China HBV CH 100 S7/8 N 22592 N/A N/A N/A N/A Resection N Y N Immunological Unknown
Parks et al[22] 69 M United States HCV N/A 22 S8 N/A 4077 37 N/A N/A Well N Y Y LNs N/A N/A
Parks et al[22] 63 M United States HCV N/A N/A S7 N/A 91 27 N/A N/A Combined N Y Y LNs N/A N/A
Parks et al[22] 67 M United States HCV LC N/A N/A PV 35689 8 N/A N/A Moderate N N Y N N/A N/A
Saito et al[23] 75 M Japan HCV CH 200 Right PV 452100 107 596000 34 N/A TACE N Y Lung Combine Portal vein thrombosis and immunological reaction
Bhardwaj et al[24] 74 F Australia Unknown N/A 90 Left N/A WNL N/A N/A N/A Well N N Y N N/A Unknown
Lim et al[25] 64 M South Korea HBV CH N/A Right N/A 17 2 12900 23 N/A N N N/A Lung, adrenal glands, LNs Immunological Herbal medicine
Tomino et al[26] 77 M Japan Alc N/A 30 S1 PV, HA 6 N/A 19 N/A Moderate Resection N N N Hypoxia Hepatic arterial and portal vein thromboses
Tsai et al[27] 74 M Taiwan HCV LC 80 Left N/A 810 WNL N/A N/A N/A N N N/A N/A N/A N/A
Okano et al[28] 77 M Japan Alc LC 50 S8 N/A 1825 51 3043 411 N/A TACE Y Y N Combine Stenosis of hepatic artery and cessation of drinking
Sasaki et al[29] 79 M Japan Alc N/A 20 S2 N/A 8 N/A N/A N/A N/A Resection N/A N N N/A Unknown
Tomishige et al[30] 76 F Japan Unknown NL 12 S6 N/A WNL N/A N/A N/A N/A Resection N N N N/A Unknown
Our case 78 M Japan NASH CH 20 S8 PV 2201 < 1 46 21 Poor N Y Y LN Immunological Hemodialysis